Blood compatibility of zinc–calcium phosphate conversion coating on Mg–1.33Li–0.6Ca alloy
Yu-Hong ZOU, Rong-Chang ZENG, Qing-Zhao WANG, Li-Jun LIU, Qian-Qian XU, Chuang WANG, Zhiwei LIU
Blood compatibility of zinc–calcium phosphate conversion coating on Mg–1.33Li–0.6Ca alloy
Magnesium alloys as a new class of biomaterials possess biodegradability and biocompatibility in comparison with currently used metal implants. However, their rapid corrosion rates are necessary to be manipulated by appropriate coatings. In this paper, a new attempt was used to develop a zinc–calcium phosphate (Zn–Ca–P) conversion coating on Mg–1.33Li–0.6Ca alloys to increase the biocompatibility and improve the corrosion resistance. In vitro blood biocompatibility of the alloy with and without the Zn–Ca–P coating was investigated to determine its suitability as a degradable medical biomaterial. Blood biocompatibility was assessed from the hemolysis test, the dynamic cruor time test, blood cell count and SEM observation of the platelet adhesion to membrane surface. The results showed that the Zn–Ca–P coating on Mg–1.33Li–0.6Ca alloys had good blood compatibility, which is in accordance with the requirements for medical biomaterials.
magnesium alloy / lithium / zinc–calcium phosphate coating / biocompatibility / biomaterial
[1] |
Bostman O, Pihlajamaki H. Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review. Biomaterials, 2000, 21(24): 2615–2621
|
[2] |
Reifenrath J, Krause A, Bormann D,
|
[3] |
Zheng Y F, Gu X N, Witte F. Biodegradable metals. Materials Science and Engineering R: Reports, 2014, 77(2): 1–34
|
[4] |
Huehnerschulte T A, Angrisani N, Rittershaus D,
|
[5] |
Williams D. New interests in magnesium. Medical Device Technology, 2006, 17(3): 9–10
|
[6] |
Vormann J. Magnesium: nutrition and metabolism. Molecular Aspects of Medicine, 2003, 24(1–3): 27–37
|
[7] |
Zeng R C, Dietzel W, Witte F,
|
[8] |
Sherriff J. Modern nutrition in health and disease. Australian Journal of Nutrition and Dietetics, 2000, 57(1): 55–56
|
[9] |
Staiger M P, Pietak A M, Huadmai J,
|
[10] |
Witte F, Fischer J, Nellesen J,
|
[11] |
Zartner P, Cesnjevar R, Singer H,
|
[12] |
Hermawan H, Dube D, Mantovani D. Developments in metallic biodegradable stents. Acta Biomaterialia, 2010, 6(5): 1693–1697
|
[13] |
Witte F, Kaese V, Switzer H,
|
[14] |
Zeng R C, Wang L, Zhang D F,
|
[15] |
Zhou W R, Zheng Y F, Leeflang M A,
|
[16] |
Zeng R C, Sun L, Zheng Y F,
|
[17] |
Zeng R C, Guo X L, Liu C L,
|
[18] |
Zhu S J, Liu Q, Qian Y F,
|
[19] |
Zomorodian A, Brusciotti F, Fernandes A,
|
[20] |
Abdal-hay A, Barakat N A M, Lim J K. Hydroxyapatite-doped poly(lactic acid) porous film coating for enhanced bioactivity and corrosion behavior of AZ31 Mg alloy for orthopedic applications. Ceramics International, 2013, 39(1): 183–195
|
[21] |
Zomorodian A, Garcia M P, Moura T,
|
[22] |
Gu X N, Li N, Zhou W R,
|
[23] |
Gao J H, Shi X Y, Yang B,
|
[24] |
Boccaccini A R, Keim S, Ma R,
|
[25] |
Zeng R C, Lan Z D, Kong L H,
|
[26] |
Lan W, Sun J C, Zhou A R,
|
[27] |
Zeng R C, Qi W C, Song Y W,
|
[28] |
Zhang C Y, Zeng R C, Liu C L,
|
[29] |
Zhang C Y, Zeng R C, Liu C L,
|
[30] |
Wen C L, Guan S K, Peng L,
|
[31] |
Wang H X, Guan S K, Wang X,
|
[32] |
Tan L L, Wang Q, Geng F,
|
[33] |
Wang Q, Tan L L, Xu W L,
|
[34] |
Xu L P, Pan F, Yu G N,
|
[35] |
Zhang S X, Li J A, Song Y,
|
[36] |
Zhang S X, Zhang X N, Zhao C L,
|
[37] |
Tapiero H, Tew K D. Trace elements in human physiology and pathology: zinc and metallothioneins. Biomedicine and Pharmacotherapy, 2003, 57(9): 399–411
|
[38] |
Stulikova I, Smola B. Mechanical properties and phase composition of potential biodegradable Mg–Zn–Mn-base alloys with addition of rare earth elements. Materials Characterization, 2010, 61(10): 952–958
|
[39] |
Zeng R C, Sun X X, Song Y W,
|
[40] |
Zeng R C, Lan Z D. Influence of bath temperature of conversion treatment process on corrosion resistance of zinc calcium phosphate conversion film on AZ31 magnesium alloy. The Chinese Journal of Nonferrous Metals, 2010, 20: 1461–1466
|
[41] |
Zeng R C, Zhang F, Lan Z D,
|
[42] |
Acker J P, Croteau I M, Yi Q L. An analysis of the bias in red blood cell hemolysis measurement using several analytical approaches. Clinica Chimica Acta, 2012, 413(21–22): 1746– 1752
|
[43] |
Huang J, Dong P, Hao W C,
|
[44] |
Zhou C R, Yi Z J. Blood-compatibility of polyurethane/liquid crystal composite membranes. Biomaterials, 1999, 20(22): 2093–2099
|
[45] |
Dong Y X, Chen Y S, Chen Q,
|
[46] |
ISO/DIS 10993-4. Biological evaluation of medical devices- Part 4: Selection of tests for interactions with blood, 2006
|
[47] |
Zhen Z, Xi T F, Zheng Y F,
|
[48] |
Wang Y, Wei M, Gao J C,
|
[49] |
Hess J R, Sparrow R L. Red blood cell hemolysis during blood bank storage: using national quality management data to answer basic scientific questions. Transfusion, 2009, 49(12): 2599–2603
|
[50] |
Gu X N, Zheng Y F, Cheng Y,
|
[51] |
Zhang E L, Yin D S, Xu L P,
|
/
〈 | 〉 |